You are viewing the site in preview mode

Skip to main content

Advertisement

Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Salivary epidermal growth factor correlates with hospitalization length in rotavirus infection

Fig. 1

a Values of EGF measured in saliva from RV-infected patients during acute phase (n = 27) and convalescence (n = 23), and in healthy controls (n = 36). Saliva samples were tested for EGF using multiplex cytokine analysis as described in the text. Results are presented as median and interquartile range EGF levels in pg/ml. A non-parametric Wilcoxon test was used to determine statistical significance between acute-phase and convalescence samples. Mann-Whitney tests were used for comparison between acute-phase and healthy controls. P-values indicated on graphs are <0.05 (*) and <0.0001 (***). b Association between salivary EGF level and length of hospitalization stay. Salivary EGF levels and symptom scores for 27 RV-infected patients were analysed as described in the text. No other significant association was detected. Spearman’s rank correlation coefficient (r2) is presented (P-value = 0.022). c Age and salivary EGF levels. No association was observed between EGF level and age

Back to article page